Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016

As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. We combined individual-level data on patients with pulmonary MDR-TB published during 2009-2016 from 25 countries. We compared patients receiving each of the injectable drug...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical infectious diseases Ročník 73; číslo 11; s. e3929
Hlavní autori:	Cegielski, J Peter, Chan, Pei-Chun, Lan, Zhiyi, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 06.12.2021
Predmet:	Aminoglycosides - therapeutic use Antitubercular Agents - pharmacology Capreomycin - pharmacology Capreomycin - therapeutic use Humans Microbial Sensitivity Tests Mycobacterium tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy meta-analysis capreomycin treatment aminoglycosides multidrug-resistant tuberculosis
ISSN:	1537-6591, 1537-6591
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!